相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Atazanavir Plus Ritonavir or Efavirenz as Part of a 3-Drug Regimen for Initial Treatment of HIV-1
Eric S. Daar et al.
ANNALS OF INTERNAL MEDICINE (2011)
Lipid profiles for nevirapine vs. atazanavir/ritonavir, both combined with tenofovir disoproxil fumarate and emtricitabine over 48 weeks, in treatment-naive HIV-1-infected patients (the ARTEN study)
D. Podzamczer et al.
HIV MEDICINE (2011)
Antiatherogenic function of HDL particle subpopulations: focus on antioxidative activities
Anatol Kontush et al.
CURRENT OPINION IN LIPIDOLOGY (2010)
Nevirapine Increases High-Density Lipoprotein Cholesterol Concentration by Stimulation of Apolipoprotein A-I Production
Remco Franssen et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2009)
Lipoprotein Particle Profiles by Nuclear Magnetic Resonance Compared With Standard Lipids and Apolipoproteins in Predicting Incident Cardiovascular Disease in Women
Samia Mora et al.
CIRCULATION (2009)
Serum lipid profiles among patients initiating ritonavir-boosted atazanavir versus efavirenz-based regimens
Anuradha Ganesan et al.
AIDS Research and Therapy (2009)
Lipoprotein changes in HIV-infected antiretroviral-naive individuals after starting antiretroviral therapy: ACTG Study A5152s
James H. Stein et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2008)
High-density lipoprotein cholesterol, high-density lipoprotein particle size, and apolipoprotein A-I: Significance for cardiovascular risk - The IDEAL and EPIC-Norfolk studies
Wim A. van der Steeg et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Relation of gemfibrozil treatment and high-density lipoprotein subpopulation profile with cardiovascular events in the Veterans Affairs High-Density Lipoprotein Intervention Trial
Bela F. Asztalos et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2008)
Long-term body composition and metabolic changes in antiretroviral naive persons randomized to protease inhibitor-, nonnucleoside reverse transcriptase inhibitor-, or protease inhibitor plus nonnucleoside reverse transcriptase inhibitor-based strategy
Judith C. Shlay et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2007)
Lipoprotein particle analysis by nuclear magnetic resonance spectroscopy
Elias J. Jeyarajah et al.
CLINICS IN LABORATORY MEDICINE (2006)
Nuclear magnetic resonance-determined lipoprotein subclass profile in the DCCT/EDIC cohort: associations with carotid intima-media thickness
T. J. Lyons et al.
DIABETIC MEDICINE (2006)
The use of the Framingham equation to predict myocardial infarctions in HIV-infected patients:: comparison with observed events in the D:A:D Study
MG Law et al.
HIV MEDICINE (2006)
Low-density lipoprotein and high-density lipoprotein particle subclasses predict coronary events and are favorably changed by gemfibrozil therapy in the veterans affairs high-density lipoprotein intervention trial
JD Otvos et al.
CIRCULATION (2006)
Is there a simple way to identify insulin-resistant individuals at increased risk of cardiovascular disease?
T McLaughlin et al.
AMERICAN JOURNAL OF CARDIOLOGY (2005)
Lipid profiles in HIV-infected patients receiving combination antiretroviral therapy: Are different antiretroviral drugs associated with different lipid profiles?
E Fontas et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
Accuracy of the triglyceride to high-density lipoprotein cholesterol ratio for prediction of the low-density lipoprotein phenotype B
V Hanak et al.
AMERICAN JOURNAL OF CARDIOLOGY (2004)
High-density lipoprotein subpopulation profile and coronary heart disease prevalence in male participants of the Framingham Offspring Study
BF Asztalos et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)
Antiinflammatory properties of HDL
PJ Barter et al.
CIRCULATION RESEARCH (2004)
Role of lipid and lipoprotein profiles in risk assessment and therapy
CM Ballantyne et al.
AMERICAN HEART JOURNAL (2003)
Nuclear magnetic resonance spectroscopy of lipoproteins and risk of coronary heart disease in the Cardiovascular Health Study
L Kuller et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2002)
Nevirapine-containing antiretroviral therapy in HIV-1 infected patients results in an anti-atherogenic lipid profile
M van der Valk et al.
AIDS (2001)
Evidence that triglycerides are an independent coronary heart disease risk factor
P Cullen
AMERICAN JOURNAL OF CARDIOLOGY (2000)
分享论文
